Herein, our study found that MSH2 protein level was significantly upregulated in glioma tissues and associated with higher degree of malignancy and poorer prognosis, which is contrary to its expression pattern in prostate cancer but in consistent with the most recent pan‐cancer study [26]. This evidence concerns the gene MSH2 and prostate cancer.